RxDoctor Payments DataLook up a doctor →

Melaine Eyster, MD

Hematology · Hershey, PANPI 1144279811

Payments from drug & device makers

$1,020,434in general payments, 2019–2025

Across 1,488 payments — averaging $685.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Spark Therapeutics, Inc.$398K
  • Novo Nordisk AS$359K
  • Bayer$104K
  • Takeda Pharmaceuticals U.S.A., Inc.$93K
  • Shire North American Group Inc$39K
  • Sanofi$28K
  • plus $309 from 2 others

What the payments were for

  • Consulting fees$2,28688%
  • Education$30912%

General payments by program year

21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,020,434 in reported general payments places this provider in the 95th percentile of 64 hematology providers in Pennsylvania.

See all hematology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$4,235
Medicare patients
35
Services billed
43

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Deferasirox16$64,891
EliquisApixaban46$45,558

Paid to pharmacies, not to this prescriber.

Other hematology in Hershey

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →